AKANVSRPRX• 28 Days (Normalized)
AKAN vs RPRX (Akanda Corp. vs Royalty Pharma plc)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AKAN Performance $3.07
-52.4%
Akanda Corp.
Normalized Baseline0.00%
RPRX Performance $58.61
+0.02%
Royalty Pharma plc
Normalized Baseline0.00%
Alpha Spread Margin RPRX LEADS
-52.42%
RPRX outperforming by 52.42%
AKANRPRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AKAN RPRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AKAN Price | AKAN Gain (%) | RPRX Price | RPRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $3.07 | -52.40% | $58.61 | +0.02% | -52.42% |
| Sep 10, 2026 | $3.00 | -53.49% | $58.75 | +0.26% | -53.75% |
| Sep 09, 2026 | $3.25 | -49.61% | $60.59 | +3.40% | -53.01% |
| Sep 08, 2026 | $3.28 | -49.15% | $60.59 | +3.40% | -52.55% |
| Sep 04, 2026 | $3.35 | -48.06% | $63.96 | +9.15% | -57.21% |
| Sep 03, 2026 | $3.67 | -43.10% | $63.88 | +9.01% | -52.11% |
| Sep 02, 2026 | $3.74 | -42.02% | $63.11 | +7.70% | -49.72% |
| Sep 01, 2026 | $3.70 | -42.64% | $62.32 | +6.35% | -48.99% |
| Aug 31, 2026 | $4.08 | -36.82% | $61.41 | +4.80% | -41.62% |
| Aug 28, 2026 | $3.89 | -39.69% | $60.85 | +3.84% | -43.53% |
| Aug 27, 2026 | $4.23 | -34.42% | $61.92 | +5.67% | -40.09% |
| Aug 26, 2026 | $4.24 | -34.26% | $61.80 | +5.46% | -39.72% |
| Aug 25, 2026 | $4.95 | -23.26% | $62.07 | +5.92% | -29.18% |
| Aug 24, 2026 | $3.71 | -42.56% | $61.33 | +4.66% | -47.22% |
| Aug 21, 2026 | $3.86 | -40.16% | $61.31 | +4.62% | -44.78% |
Page 1 of 2